Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
Abroad (travel likely)RecruitingPHASE2
Conditions
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015Contact: Principal Investigator (Ricardo D. Parrondo, M.D.)
Study leads
Ricardo D. Parrondo, M.D.
Principal Investigator
Mayo Clinic